Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Bioinformatics (Oxford, England)|August 13, 2005
SPLINDID: a semi-parametric, model-based method for obtaining transcription rates and gene regulation parameters from genomic and proteomic expression profilesKavitha Bhasi, Alan Forrest, Murali RamanathanPharmaceutical Research|March 22, 2006
Application of SPLINDID, a semiparametric, model-based method for pharmacogenomic modeling of mRNA dynamicsKavitha Bhasi, Alan Forrest, Murali RamanathanPharmaceutical Research|June 8, 2004
Analysis of pharmacokinetics, pharmacodynamics, and pharmacogenomics data sets using VizStruct, a novel multidimensional visualization techniqueKavitha Bhasi, Li Zhang, Aidong Zhang, et al.Nucleic Acids Research|August 11, 2006
Information-theoretic identification of predictive SNPs and supervised visualization of genome-wide association studiesKavitha Bhasi, Li Zhang, Daniel Brazeau, et al.Bioinformatics (Oxford, England)|April 15, 2006
VizStruct for visualization of genome-wide SNP analysesKavitha Bhasi, Li Zhang, Daniel Brazeau, et al.Journal of Neuroimmunology|November 28, 2006
Pharmacogenetics of MXA SNPs in interferon-beta treated multiple sclerosis patientsBianca Weinstock-Guttman, Miriam Tamaño-Blanco, Kavitha Bhasi, et al.Clinical Drug Investigation|January 18, 2013
Effect of concomitant administration of trospium chloride extended release on the steady-state pharmacokinetics of metformin in healthy adultsMichael G Oefelein, Warren Tong, Sam Kerr, et al.Journal of Neuroimmunology|October 28, 2008
Genomic effects of once-weekly, intramuscular interferon-beta1a treatment after the first dose and on chronic dosing: Relationships to 5-year clinical outcomes in multiple sclerosis patientsBianca Weinstock-Guttman, Kavitha Bhasi, Darlene Badgett, et al.Archives of Neurology|November 15, 2006
Interferon inhibitory activity in patients with multiple sclerosisKailash Chadha, Bianca Weinstock-Guttman, Robert Zivadinov, et al.Pageof 1